Stay updated on Azacitidine and Pembrolizumab in MDS Clinical Trial
Sign up to get notified when there's something new on the Azacitidine and Pembrolizumab in MDS Clinical Trial page.

Latest updates to the Azacitidine and Pembrolizumab in MDS Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page shows a new revision version (v3.5.3) replacing the previous v3.5.2, indicating a small update to the page content or metadata. This change updates the revision history but does not alter substantive study information.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedRevision: v3.5.2 has been added and Revision: v3.5.0 has been removed.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No visible changes to study content or page functionality.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the page footer.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision: v3.4.2 was added and notices for Revision: v3.4.1 and the government funding lapse were removed.SummaryDifference0.4%

- Check98 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the revision label to v3.4.1. The previous revision label v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Azacitidine and Pembrolizumab in MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine and Pembrolizumab in MDS Clinical Trial page.